Kumar R - Search Results

1

Co-incubation with core proteins of HBV and HCV leads to modulation of human dendritic cells.

Agrawal A, Samrat SK, Agrawal B, Tyrrell DL, Kumar R. Agrawal A, et al. Among authors: kumar r. Viral Immunol. 2014 Oct;27(8):412-7. doi: 10.1089/vim.2014.0056. Epub 2014 Aug 22. Viral Immunol. 2014. PMID: 25148301

2

Design and synthesis of novel 5-substituted acyclic pyrimidine nucleosides as potent and selective inhibitors of hepatitis B virus.

Kumar R, Nath M, Tyrrell DL. Kumar R, et al. J Med Chem. 2002 May 9;45(10):2032-40. doi: 10.1021/jm010410d. J Med Chem. 2002. PMID: 11985471

3

Novel treatment options for hepatitis B virus infection.

Kumar R, Agrawal B. Kumar R, et al. Curr Opin Investig Drugs. 2004 Feb;5(2):171-8. Curr Opin Investig Drugs. 2004. PMID: 15043391 Review.

4

Design and studies of novel 5-substituted alkynylpyrimidine nucleosides as potent inhibitors of mycobacteria.

Rai D, Johar M, Manning T, Agrawal B, Kunimoto DY, Kumar R. Rai D, et al. Among authors: kumar r. J Med Chem. 2005 Nov 3;48(22):7012-7. doi: 10.1021/jm058167w. J Med Chem. 2005. PMID: 16250660

5

Inhibition of hepatitis B virus (HBV) replication by pyrimidines bearing an acyclic moiety: effect on wild-type and mutant HBV.

Semaine W, Johar M, Tyrrell DL, Kumar R, Agrawal B. Semaine W, et al. Among authors: kumar r. J Med Chem. 2006 Mar 23;49(6):2049-54. doi: 10.1021/jm058271d. J Med Chem. 2006. PMID: 16539393

6

Effect of various pyrimidines possessing the 1-[(2-hydroxy-1-(hydroxymethyl)ethoxy)methyl] moiety, able to mimic natural 2'-deoxyribose, on wild-type and mutant hepatitis B virus replication.

Kumar R, Semaine W, Johar M, Tyrrell DL, Agrawal B. Kumar R, et al. J Med Chem. 2006 Jun 15;49(12):3693-700. doi: 10.1021/jm060102l. J Med Chem. 2006. PMID: 16759112

7

Growth inhibition of Mycobacterium bovis, Mycobacterium tuberculosis and Mycobacterium avium in vitro: effect of 1-beta-D-2'-arabinofuranosyl and 1-(2'-deoxy-2'-fluoro-beta-D-2'-ribofuranosyl) pyrimidine nucleoside analogs.

Johar M, Manning T, Tse C, Desroches N, Agrawal B, Kunimoto DY, Kumar R. Johar M, et al. Among authors: kumar r. J Med Chem. 2007 Jul 26;50(15):3696-705. doi: 10.1021/jm0703901. Epub 2007 Jun 29. J Med Chem. 2007. PMID: 17602465

8

Inhibition of Mycobacterium tuberculosis, Mycobacterium bovis, and Mycobacterium avium by novel dideoxy nucleosides.

Rai D, Johar M, Srivastav NC, Manning T, Agrawal B, Kunimoto DY, Kumar R. Rai D, et al. Among authors: kumar r. J Med Chem. 2007 Sep 20;50(19):4766-74. doi: 10.1021/jm070391t. Epub 2007 Aug 16. J Med Chem. 2007. PMID: 17696514

9

Priming and stimulation of hepatitis C virus-specific CD4+ and CD8+ T cells against HCV antigens NS4, NS5a or NS5b from HCV-naive individuals: implications for prophylactic vaccine.

Li W, Krishnadas DK, Kumar R, Tyrrell DL, Agrawal B. Li W, et al. Among authors: kumar r. Int Immunol. 2008 Jan;20(1):89-104. doi: 10.1093/intimm/dxm121. Epub 2007 Nov 15. Int Immunol. 2008. PMID: 18006878

10

In vitro activation and differentiation of naïve CD4+ and CD8+ T cells into HCV core- and NS3-specific armed effector cells: a new role for CD4+ T cells.

Krishnadas DK, Li W, Kumar R, Tyrrell LJ, Agrawal B. Krishnadas DK, et al. Among authors: kumar r. Cell Immunol. 2009;259(2):141-9. doi: 10.1016/j.cellimm.2009.06.009. Epub 2009 Jun 23. Cell Immunol. 2009. PMID: 19616202

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

19,563 results

Search Page

Filters